• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Factors associated with influenza vaccination among adult cancer patients: A case-control study

tetano

Editor, Senior Moderator
Clin Microbiol Infect. 2014 Mar 22. doi: 10.1111/1469-0691.12625. [Epub ahead of print]
Factors associated with influenza vaccination among adult cancer patients: A case-control study.
Vinograd I1, Baslo R, Eliakim-Raz N, Farbman L, Taha A, Sakhnini A, Lador A, Stemmer SM, Gafter-Gvili A, Fraser D, Leibovici L, Paul M.
Author information
Abstract

Influenza vaccination is recommended for cancer patients, however adherence is low. We aimed to identify predicting factors for vaccination among cancer patients. We conducted a case-control analysis of a patient cohort in the 2010-2011 influenza season. We included adult cancer patients with solid malignancies undergoing chemotherapy and haematological patients with active disease. Patients who died between October-November 2010 (N=43) were excluded from analysis. Cases received the 2011 seasonal influenza vaccine and controls did not. Data were obtained from patients' records and validated through personal interviews. We collected socio-demographic information, data on the malignancy and co-morbidities and triggers for vaccination and non-vaccination. We performed bivariate and multivariable analyses, in which vaccination status was the dependent variable. Of 806 patients included in analysis, 387 (48%) were vaccinated. Variables associated with vaccination on bivariate analysis were older age, higher socio-economic status, lower crowding-index, marital status (widowed >married >singles), malignancy type (haematological >solid tumours) and time from diagnosis, low-risk malignancy, diabetes, past vaccination, country of birth (non-Russian origin) and physicians' recommendations. Predicting factors found to be independently associated with vaccination on multivariable analysis were past vaccinations, low-risk malignancy and country of birth. In the analysis conducted among interviewees (N=561), recommendations from the oncologist (OR=10.7 95% CI 5.4-21.2) and from the primary care physician (OR=3.35 95% CI 2.05-5.49) were strong predictors for vaccination. We conclude that "habitual vaccinees" continue influenza vaccinations when ill with cancer. Physicians' recommendations, especially the oncologist's, have a major influence on patients' compliance with influenza vaccination. This article is protected by copyright. All rights reserved.

This article is protected by copyright. All rights reserved.
KEYWORDS:

Chemotherapy, Influenza, Neoplasm, Vaccine, adherence

PMID:
24655107
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24655107
 
Back
Top Bottom